A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.
UNLABELLED: This paper provides a framework for the development of national guidelines for the management of glucocorticoid-induced osteoporosis in men and women aged 18 years and over in whom oral glucocorticoid therapy is considered for 3 months or longer. INTRODUCTION: The need for updated guidel...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Sprog: | English |
| Udgivet: |
2012
|
| _version_ | 1826270854657343488 |
|---|---|
| author | Lekamwasam, S Adachi, J Agnusdei, D Bilezikian, J Boonen, S Borgström, F Cooper, C Diez Perez, A Eastell, R Hofbauer, L Kanis, J Langdahl, B Lesnyak, O Lorenc, R McCloskey, E Messina, O Napoli, N Obermayer-Pietsch, B Ralston, S Sambrook, P Silverman, S Sosa, M Stepan, J Suppan, G Wahl, D |
| author_facet | Lekamwasam, S Adachi, J Agnusdei, D Bilezikian, J Boonen, S Borgström, F Cooper, C Diez Perez, A Eastell, R Hofbauer, L Kanis, J Langdahl, B Lesnyak, O Lorenc, R McCloskey, E Messina, O Napoli, N Obermayer-Pietsch, B Ralston, S Sambrook, P Silverman, S Sosa, M Stepan, J Suppan, G Wahl, D |
| author_sort | Lekamwasam, S |
| collection | OXFORD |
| description | UNLABELLED: This paper provides a framework for the development of national guidelines for the management of glucocorticoid-induced osteoporosis in men and women aged 18 years and over in whom oral glucocorticoid therapy is considered for 3 months or longer. INTRODUCTION: The need for updated guidelines for Europe and other parts of the world was recognised by the International Osteoporosis Foundation and the European Calcified Tissue Society, which set up a joint Guideline Working Group at the end of 2010. METHODS AND RESULTS: The epidemiology of GIO is reviewed. Assessment of risk used a fracture probability-based approach, and intervention thresholds were based on 10-year probabilities using FRAX. The efficacy of intervention was assessed by a systematic review. CONCLUSIONS: Guidance for glucocorticoid-induced osteoporosis is updated in the light of new treatments and methods of assessment. National guidelines derived from this resource need to be tailored within the national healthcare framework of each country. |
| first_indexed | 2024-03-06T21:47:22Z |
| format | Journal article |
| id | oxford-uuid:4a0e120b-2166-4f25-a7ed-66f90472b154 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:47:22Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:4a0e120b-2166-4f25-a7ed-66f90472b1542022-03-26T15:35:25ZA framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4a0e120b-2166-4f25-a7ed-66f90472b154EnglishSymplectic Elements at Oxford2012Lekamwasam, SAdachi, JAgnusdei, DBilezikian, JBoonen, SBorgström, FCooper, CDiez Perez, AEastell, RHofbauer, LKanis, JLangdahl, BLesnyak, OLorenc, RMcCloskey, EMessina, ONapoli, NObermayer-Pietsch, BRalston, SSambrook, PSilverman, SSosa, MStepan, JSuppan, GWahl, DUNLABELLED: This paper provides a framework for the development of national guidelines for the management of glucocorticoid-induced osteoporosis in men and women aged 18 years and over in whom oral glucocorticoid therapy is considered for 3 months or longer. INTRODUCTION: The need for updated guidelines for Europe and other parts of the world was recognised by the International Osteoporosis Foundation and the European Calcified Tissue Society, which set up a joint Guideline Working Group at the end of 2010. METHODS AND RESULTS: The epidemiology of GIO is reviewed. Assessment of risk used a fracture probability-based approach, and intervention thresholds were based on 10-year probabilities using FRAX. The efficacy of intervention was assessed by a systematic review. CONCLUSIONS: Guidance for glucocorticoid-induced osteoporosis is updated in the light of new treatments and methods of assessment. National guidelines derived from this resource need to be tailored within the national healthcare framework of each country. |
| spellingShingle | Lekamwasam, S Adachi, J Agnusdei, D Bilezikian, J Boonen, S Borgström, F Cooper, C Diez Perez, A Eastell, R Hofbauer, L Kanis, J Langdahl, B Lesnyak, O Lorenc, R McCloskey, E Messina, O Napoli, N Obermayer-Pietsch, B Ralston, S Sambrook, P Silverman, S Sosa, M Stepan, J Suppan, G Wahl, D A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. |
| title | A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. |
| title_full | A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. |
| title_fullStr | A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. |
| title_full_unstemmed | A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. |
| title_short | A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. |
| title_sort | framework for the development of guidelines for the management of glucocorticoid induced osteoporosis |
| work_keys_str_mv | AT lekamwasams aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT adachij aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT agnusdeid aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT bilezikianj aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT boonens aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT borgstromf aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT cooperc aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT diezpereza aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT eastellr aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT hofbauerl aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT kanisj aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT langdahlb aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT lesnyako aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT lorencr aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT mccloskeye aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT messinao aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT napolin aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT obermayerpietschb aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT ralstons aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT sambrookp aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT silvermans aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT sosam aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT stepanj aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT suppang aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT wahld aframeworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT lekamwasams frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT adachij frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT agnusdeid frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT bilezikianj frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT boonens frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT borgstromf frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT cooperc frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT diezpereza frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT eastellr frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT hofbauerl frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT kanisj frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT langdahlb frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT lesnyako frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT lorencr frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT mccloskeye frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT messinao frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT napolin frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT obermayerpietschb frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT ralstons frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT sambrookp frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT silvermans frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT sosam frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT stepanj frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT suppang frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis AT wahld frameworkforthedevelopmentofguidelinesforthemanagementofglucocorticoidinducedosteoporosis |